Document is current
Any future updates will be listed below
-
Authors
Hecker, Michael https://orcid.org/0000-0001-7015-3094
Fitzner, Brit
Boxberger, Nina
Putscher, Elena
Engelmann, Robby
Bergmann, Wendy
Müller, Michael
Ludwig-Portugall, Isis
Schwartz, Margit
Meister, Stefanie
Dudesek, Ales
Winkelmann, Alexander
Koczan, Dirk
Zettl, Uwe Klaus
-
Funding
Funding for this research was provided by:
Stiftung der Deutschen Wirtschaft
Landesgraduiertenförderung Mecklenburg-Vorpommern
Universitätsmedizin Rostock
- License Information
-
More Information
Article History
Received: 12 October 2022
Accepted: 25 July 2023
First Online: 2 August 2023
Declarations
:
: This study was conducted with approvals by the local ethics committee of the University of Rostock (permit numbers A 2014-0112 and A 2016-0188) and in compliance with the principles of the Declaration of Helsinki. All subjects gave prior written informed consent for the scientific use of their biosamples.
: Not applicable.
: MH received speaking fees and travel funds from Bayer HealthCare, Biogen, Merck, Novartis and Teva. NB received travel funds from Novartis. IL-P is an employee of Miltenyi Biotec. AW received speaking fees and travel funds from Biogen, GlaxoSmithKline, Merck Serono, Novartis and Sanofi Genzyme. UKZ received research support as well as speaking fees and travel funds from Alexion, Almirall, Bayer HealthCare, Biogen, Bristol Myers Squibb, Janssen, Merck Serono, Novartis, Roche, Sanofi Genzyme, Teva as well as EU, BMBF, BMWi and DFG. BF, EP, RE, WB, MM, MS, SM, AD and DK declare that they have no competing interests.
